Biochemistry
Fatty Acid Synthesis
Building palmitate from acetyl-CoA — fatty acid synthase, malonyl-CoA, NADPH, and the ACC switch
Fatty acid synthesis is the cytosolic anabolic pathway that assembles long-chain fatty acids two carbons at a time, condensing acetyl-CoA and malonyl-CoA on the fatty acid synthase megaenzyme to build the 16-carbon saturated fatty acid palmitate. Each turn of the cycle adds one two-carbon unit through condensation, reduction, dehydration, and a second reduction; seven turns and eight acetyl units later, the enzyme's thioesterase snips off a finished palmitate. The full bill is 8 acetyl-CoA, 7 ATP, and 14 NADPH per chain. The committed, rate-limiting step — carboxylation of acetyl-CoA to malonyl-CoA by biotin-dependent acetyl-CoA carboxylase — was the mechanistic prize claimed by Feodor Lynen and Salih Wakil around 1959–1961; Lynen shared the 1964 Nobel Prize in Physiology or Medicine. The pathway is the reductive mirror image of beta-oxidation, and its regulation keeps a cell from building and burning fat at the same time.
- LocationCytosol (not mitochondria)
- Main productPalmitate (16:0)
- Per cycle+2 carbons, 2 NADPH
- Per palmitate8 acetyl-CoA, 7 ATP, 14 NADPH
- Committed stepACC → malonyl-CoA
- MechanismLynen & Wakil, ~1960
Interactive visualization
Press play, or step through manually. The visualization is yours to drive — try it before reading on.
Watch the 60-second explainer
A condensed visual walkthrough — narrated, captioned, under a minute.
Why fatty acid synthesis matters
- It is how the body stores excess energy. Carbohydrate and protein eaten beyond immediate need are converted into acetyl-CoA and then into fatty acids by de novo lipogenesis, esterified into triacylglycerols, and packed into adipose tissue. Each gram of fat stores about 9 kcal — more than twice the 4 kcal of carbohydrate — and does so anhydrously, which is why fat, not glycogen, is the body's long-term fuel reserve.
- It builds the membranes of every new cell. Palmitate and its derivatives (stearate, oleate, phospholipid acyl chains) are the structural backbone of the lipid bilayer. Rapidly dividing tissues — fetal tissue, intestinal epithelium, and tumors — run fatty acid synthase at high levels precisely because they must manufacture membrane faster than they can import it.
- It runs hardest in liver, lactating mammary gland, and adipose. The liver is the central lipogenic factory that exports fat as VLDL; the lactating mammary gland pours synthesized fatty acids into milk; adipocytes both make and store them. In humans on a typical diet, hepatic de novo lipogenesis is modest, but it rises sharply with high-carbohydrate or high-fructose intake — a driver of non-alcoholic fatty liver disease (NAFLD/MASLD).
- Fatty acid synthase is a cancer target. FASN is overexpressed in many carcinomas (breast, prostate, ovarian) and correlates with poor prognosis; tumor cells depend on de novo synthesis rather than dietary lipid. FASN inhibitors such as TVB-2640 (denifanstat) have advanced through clinical trials in cancer and steatohepatitis.
- ACC inhibitors treat fatty liver. Because acetyl-CoA carboxylase gates the whole pathway, blocking it lowers hepatic lipogenesis. The liver-targeted ACC inhibitor firsocostat (GS-0976) reduces liver fat in MASH trials, illustrating how a single committed enzyme can be drugged to shift whole-body lipid balance.
- Malonyl-CoA links synthesis to appetite. In the hypothalamus, malonyl-CoA levels act as a sensor of energy status: raising them (by inhibiting fatty acid synthase with the compound C75) suppresses food intake in mice, tying the biochemistry of lipogenesis directly to the neural control of eating.
- Palmitate is a signaling lipid too. Beyond storage, palmitate is attached to proteins in S-palmitoylation, a reversible modification that targets proteins like Ras and many ion channels to specific membranes — so the product of this pathway also tunes cell signaling.
Common misconceptions
- "Fatty acid synthesis is just beta-oxidation run backward." It is the chemical opposite in direction — condensation-reduction-dehydration-reduction versus oxidation-hydration-oxidation-thiolysis — but it uses different enzymes, a different compartment, a different reductant (NADPH vs FAD/NAD+), a different carrier (ACP vs CoA), and even the opposite stereochemistry of the 3-hydroxyacyl intermediate (D vs L). Evolution built two separate machines so the cell can regulate them independently.
- "Malonyl-CoA adds three carbons." Malonyl-CoA carries three carbons, but during condensation its terminal carboxyl is lost as CO2, so only two carbons are actually added to the chain. That released CO2 is the same carbon that acetyl-CoA carboxylase attached one step earlier — the cell essentially borrows a carbon to make the chemistry favorable, then gives it back.
- "The CO2 fixed by ACC ends up in the fatty acid." It does not. Isotope-labeling experiments in the 1950s showed the bicarbonate carbon incorporated into malonyl-CoA is released again as CO2 during condensation and never appears in palmitate. Its role is purely catalytic — priming the two-carbon unit for a favorable, decarboxylative Claisen condensation.
- "NADH powers fatty acid synthesis." No — the reductant is NADPH, chemically distinct by a single phosphate but metabolically segregated. NADH feeds the electron transport chain to make ATP; NADPH drives reductive biosynthesis. Cells even maintain the two pools at very different redox ratios so oxidation and biosynthesis do not interfere.
- "Fatty acid synthase makes all the fatty acids you need." FASN essentially only makes palmitate. Longer chains come from ER elongases, double bonds come from desaturases (SCD1 and others), and the omega-6 and omega-3 polyunsaturated fatty acids cannot be made at all in mammals — they are dietary essentials because human desaturases cannot introduce a double bond past carbon 9.
- "In humans, fatty acid synthase is many separate enzymes." In animals, all seven catalytic activities plus the ACP live on a single 270-kDa polypeptide that dimerizes — a type I megasynthase. That fused architecture is a mammalian and fungal feature. Bacteria and plant chloroplasts use a type II system of discrete, freely diffusing enzymes, which is why type II FAS is an attractive antibiotic and herbicide target with no human counterpart.
How fatty acid synthesis works, step by step
The pathway starts with a supply problem. The two-carbon building block, acetyl-CoA, is generated in the mitochondrial matrix but cannot cross the inner mitochondrial membrane, while all the synthetic enzymes sit in the cytosol. The cell solves this with the citrate shuttle: mitochondrial acetyl-CoA condenses with oxaloacetate to make citrate, citrate is exported by the tricarboxylate carrier, and cytosolic ATP-citrate lyase cleaves it back into acetyl-CoA and oxaloacetate at the cost of one ATP. The oxaloacetate is reduced to malate, and malic enzyme oxidatively decarboxylates malate to pyruvate, generating one cytosolic NADPH in the process. So the shuttle delivers both carbon and part of the reducing power; the remainder of the 14 NADPH per palmitate comes from the pentose phosphate pathway.
The committed step is next. Acetyl-CoA carboxylase (ACC), a biotin-dependent enzyme, uses one ATP and bicarbonate to carboxylate acetyl-CoA into malonyl-CoA. This is the rate-limiting, irreversible, and most heavily regulated reaction of the whole pathway — the metabolic switch that decides whether a cell will build fat at all. Citrate activates ACC by polymerizing it into active filaments; the end product palmitoyl-CoA and AMPK-mediated phosphorylation switch it off.
Now the fatty acid synthase (FASN) assembly line runs. In animals it is a single 270-kDa polypeptide with seven catalytic domains plus an acyl carrier protein (ACP) arm, working as a homodimer. Priming loads an acetyl group onto the enzyme and a malonyl group onto the ACP's phosphopantetheine arm (via the malonyl/acetyl transacylase, MAT). Then each elongation cycle runs four reactions in fixed order:
- 1. Condensation (KS, β-ketoacyl synthase). The acyl group is transferred onto malonyl-ACP; malonyl's carboxyl leaves as CO2, and the two fragments join into a β-ketoacyl chain that is now two carbons longer. The decarboxylation is what makes this bond-forming step favorable.
- 2. Reduction (KR, β-ketoacyl reductase). The β-keto group is reduced to a D-β-hydroxyl using one NADPH.
- 3. Dehydration (DH, β-hydroxyacyl dehydratase). Water is removed, creating a trans double bond (an enoyl intermediate).
- 4. Reduction (ER, enoyl reductase). The double bond is reduced to a fully saturated acyl chain using a second NADPH.
After each cycle the saturated chain is passed back to the KS domain, a fresh malonyl is loaded onto ACP, and the cycle repeats. Two carbons are added per turn and two NADPH are spent per turn. After seven cycles the chain reaches 16 carbons, and the thioesterase (TE) domain hydrolyzes the finished palmitate off the ACP. Summed up: 8 acetyl-CoA (1 primer + 7 carboxylated to malonyl) + 7 ATP (at ACC) + 14 NADPH (two per cycle) yield one palmitate + 8 CoA + 6 H2O + 7 ADP + 7 Pi + 14 NADP+.
Palmitate is only the starting point. On the endoplasmic reticulum, elongases (ELOVL family) extend it to stearate (18:0) and beyond, and desaturases — chiefly stearoyl-CoA desaturase-1 (SCD1) — introduce cis double bonds using molecular oxygen and cytochrome b5, converting stearate to oleate (18:1). Because mammalian desaturases cannot act beyond carbon 9, linoleic (omega-6) and alpha-linolenic (omega-3) acids remain dietary essentials.
Fatty acid synthesis vs beta-oxidation
| Feature | Fatty acid synthesis (lipogenesis) | Beta-oxidation |
|---|---|---|
| Direction | Anabolic — builds fatty acids | Catabolic — degrades fatty acids |
| Location | Cytosol | Mitochondrial matrix |
| Carbon unit | Adds C2 from malonyl-CoA | Removes C2 as acetyl-CoA |
| Acyl carrier | ACP (phosphopantetheine arm of FASN) | Coenzyme A |
| Electron carrier | NADPH (consumed, reductant) | FAD → FADH2 and NAD+ → NADH (produced) |
| Enzyme organization | One multifunctional polypeptide (type I) | Four separate enzymes |
| 3-hydroxyacyl stereochemistry | D-isomer | L-isomer |
| Committed / control enzyme | Acetyl-CoA carboxylase (ACC) | Carnitine palmitoyltransferase-1 (CPT-1) |
| Regulation by malonyl-CoA | Is the substrate; product feedback-inhibits ACC | Malonyl-CoA inhibits CPT-1, blocking entry |
| Energetics (per C16) | Costs 7 ATP + 14 NADPH | Yields ~106 ATP (net) on full oxidation |
Where the carbon and reducing power come from
| Requirement | Source | Enzyme / carrier | Cost or yield |
|---|---|---|---|
| Acetyl-CoA (carbon) | Mitochondrial acetyl-CoA exported as citrate | Tricarboxylate carrier → ATP-citrate lyase | 1 ATP per citrate cleaved |
| NADPH (part) | Malate → pyruvate in cytosol | Malic enzyme (ME1) | +1 NADPH per acetyl exported |
| NADPH (bulk) | Glucose-6-phosphate oxidation | Pentose phosphate pathway (G6PD) | +2 NADPH per G6P |
| Malonyl-CoA (activated unit) | Acetyl-CoA + bicarbonate | Acetyl-CoA carboxylase (biotin) | 1 ATP per malonyl-CoA |
| Chain elongation | 7 condensation cycles on FASN | KS-KR-DH-ER-ACP-TE domains | 2 NADPH per cycle |
A short history and famous experiments
- Feodor Lynen and coenzyme A (1950s). Lynen isolated and characterized the CoA thioesters at the heart of fatty acid metabolism, work for which he shared the 1964 Nobel Prize in Physiology or Medicine with Konrad Bloch (for cholesterol and fatty acid metabolism). He worked out the enzymology of the fatty acid synthase complex and the role of the acyl carrier's thiol arm.
- Salih Wakil and the malonyl-CoA discovery (1958–1961). Wakil showed that fatty acid synthesis required CO2 (bicarbonate) even though the final product contained none of it, and identified malonyl-CoA as the true elongation substrate. This resolved the paradox of a bicarbonate requirement in a molecule with no added carboxyl carbon: the CO2 is added by ACC and released again during condensation. Wakil later characterized the multifunctional animal synthase.
- The acetyl-CoA carboxylase / citrate activation work (Vagelos, Numa, Lane). Studies through the 1960s established ACC as the rate-limiting enzyme and citrate as its allosteric activator that polymerizes the enzyme into active filaments — a rare case where an enzyme's oligomeric state directly reports metabolic status. Roy Vagelos and colleagues also defined the acyl carrier protein and its phosphopantetheine prosthetic group.
- Isotope tracing of the fixed carbon. Radiolabeled 14C-bicarbonate experiments demonstrated that the carbon fixed by ACC into malonyl-CoA is lost as CO2 at condensation and never appears in palmitate — the clean proof that ACC's carboxylation is catalytic priming, not carbon incorporation.
- Structural biology of the megasynthase (2006–2008). X-ray and cryo-EM structures of mammalian and fungal fatty acid synthase (notably from the Ban lab) revealed the giant, barrel-shaped homodimer with its reaction chambers and the swinging ACP arm that ferries the growing chain between catalytic domains — a physical picture of the assembly line inferred decades earlier from enzymology.
Frequently asked questions
Where does fatty acid synthesis take place in the cell?
Fatty acid synthesis happens in the cytosol, physically separated from beta-oxidation, which runs in the mitochondrial matrix. This compartmentation is the whole point: it lets a cell build fat and burn fat by different routes, on different enzymes, using different cofactors, without the two pathways short-circuiting into a futile cycle. Because the raw material — acetyl-CoA — is generated inside the mitochondrion (from pyruvate, amino acids, and beta-oxidation) and cannot cross the inner mitochondrial membrane, cells export it disguised as citrate through the citrate shuttle. In the cytosol, ATP-citrate lyase cleaves citrate back into acetyl-CoA and oxaloacetate. The synthetic enzymes — acetyl-CoA carboxylase and fatty acid synthase — are cytosolic, and in mammals the reducing power comes from cytosolic NADPH, not the mitochondrial NADH used to make ATP. In plants and many bacteria, de novo synthesis instead occurs in the chloroplast stroma or the cytoplasm on a dissociated, multi-protein type II system.
What is the role of malonyl-CoA in fatty acid synthesis?
Malonyl-CoA is the activated two-carbon donor for every elongation cycle, even though it carries three carbons. Acetyl-CoA carboxylase (ACC) uses biotin, bicarbonate, and one ATP to carboxylate acetyl-CoA into malonyl-CoA — the committed and rate-limiting step of the pathway. Fatty acid synthase then condenses malonyl-CoA with the growing acyl chain, and in that condensation the newly added carboxyl group is released as CO2. That decarboxylation is thermodynamically decisive: it makes the otherwise unfavorable carbon-carbon bond formation strongly downhill, so the cell effectively spends the energy of one ATP (invested when the carboxyl was added) to drive each condensation forward. Malonyl-CoA also has a second, regulatory job: it allosterically inhibits carnitine palmitoyltransferase-1 (CPT-1), the gate for fatty acid entry into mitochondria, so a cell actively making fat is simultaneously blocked from burning it.
How many ATP and NADPH are needed to make one palmitate?
Building one molecule of palmitate (16 carbons) from 8 molecules of acetyl-CoA requires 7 ATP and 14 NADPH. The 7 ATP are spent by acetyl-CoA carboxylase, one for each of the 7 malonyl-CoA molecules formed (the eighth two-carbon unit is the priming acetyl group and is not carboxylated). The 14 NADPH are consumed by the two reductive steps of each of the seven elongation cycles — the beta-ketoacyl reductase and the enoyl reductase each use one NADPH per cycle, so 2 per cycle times 7 cycles equals 14. The overall stoichiometry is: 8 acetyl-CoA + 7 ATP + 14 NADPH + 14 H+ yields palmitate + 8 CoA + 6 H2O + 7 ADP + 7 Pi + 14 NADP+. Note this counts only the synthesis proper; exporting the 8 acetyl units from the mitochondria as citrate costs additional ATP at ATP-citrate lyase.
How is fatty acid synthesis different from beta-oxidation?
They are chemical mirror images but not simple reversals. Fatty acid synthesis is anabolic, cytosolic, builds chains two carbons at a time from malonyl-CoA, uses NADPH as the reductant, carries intermediates on the acyl carrier protein (ACP) domain of a single multifunctional fatty acid synthase, and stereochemically passes through D-3-hydroxyacyl intermediates. Beta-oxidation is catabolic, mitochondrial, removes two carbons at a time as acetyl-CoA, uses FAD and NAD+ as oxidants (producing FADH2 and NADH), carries intermediates on coenzyme A, is run by four separate enzymes, and passes through L-3-hydroxyacyl intermediates. Because malonyl-CoA inhibits CPT-1, the two pathways are also reciprocally regulated: when synthesis is on, oxidation is off, preventing a wasteful futile cycle in which a cell would build and immediately burn the same fatty acid, dissipating ATP as heat.
What is the citrate shuttle and why is it needed?
The citrate shuttle is the transport system that moves acetyl units from the mitochondrial matrix, where they are made, to the cytosol, where fatty acids are built. Acetyl-CoA itself cannot cross the inner mitochondrial membrane. So when mitochondrial acetyl-CoA is abundant (fed state, high energy charge), it condenses with oxaloacetate to form citrate, which is exported by the tricarboxylate carrier. In the cytosol, ATP-citrate lyase cleaves citrate — at the cost of one ATP — back into acetyl-CoA and oxaloacetate. The oxaloacetate is reduced to malate and then oxidatively decarboxylated by malic enzyme, generating one cytosolic NADPH and pyruvate that returns to the mitochondrion. Elegantly, this loop delivers both the carbon (acetyl-CoA) and part of the reducing power (NADPH) that lipogenesis needs; the rest of the NADPH comes from the pentose phosphate pathway.
How is acetyl-CoA carboxylase regulated?
Acetyl-CoA carboxylase (ACC) is the master switch of fatty acid synthesis and is controlled at three levels. Allosterically, citrate promotes its polymerization into long, active filaments, so a high-energy fed state directly turns it on, while the end product palmitoyl-CoA depolymerizes and inhibits it — classic feedback. Covalently, ACC is a substrate of AMP-activated protein kinase (AMPK): when the AMP:ATP ratio rises during energy stress, AMPK phosphorylates ACC (at Ser79 on ACC1) and shuts it off, whereas insulin activates a protein phosphatase that dephosphorylates and reactivates it. Transcriptionally, insulin and a carbohydrate-rich diet raise ACC (and FASN) expression through the sterol-regulatory-element-binding protein SREBP-1c and the carbohydrate-response-element-binding protein ChREBP, so chronic overfeeding upregulates the whole lipogenic program. This layered control makes ACC the pharmacological target of drugs such as the ACC inhibitor firsocostat for fatty liver disease.
Why is palmitate the main product, and what happens to longer or unsaturated fatty acids?
Fatty acid synthase releases the chain when it reaches 16 carbons because the thioesterase (TE) domain recognizes and hydrolyzes the palmitoyl group off the acyl carrier protein; the enzyme is essentially a 16-carbon ruler. Everything beyond palmitate is made by separate systems. Elongases (ELOVL family) on the cytosolic face of the endoplasmic reticulum add two-carbon units from malonyl-CoA to make stearate (18:0) and longer chains. Desaturases — chiefly stearoyl-CoA desaturase-1 (SCD1), an ER enzyme using molecular oxygen and cytochrome b5 — introduce cis double bonds, converting stearate to oleate (18:1). Mammals cannot place double bonds beyond carbon 9, which is exactly why linoleic acid (omega-6) and alpha-linolenic acid (omega-3) are essential fatty acids that must come from the diet.